Core Viewpoint - The company intends to acquire significant equity stakes in multiple health management and medical examination companies through a share issuance, with a focus on ensuring the independence and fairness of the asset evaluation process [1][2][3] Group 1: Transaction Overview - The company plans to purchase 84% of Hunan Meinian Health Examination Center, 81% of Ningde Meinian Health Management, 75% of Yantai Meinian Health Management, and several other stakes in various health management companies [1] - The total stakes being acquired include significant minority interests in several companies, indicating a broad expansion strategy in the health management sector [1] Group 2: Evaluation Process - The company has engaged Jinzheng (Shanghai) Asset Appraisal Co., Ltd. as the asset evaluation agency, which is compliant with the Securities Law and has the necessary qualifications and experience [2] - The evaluation is based on a reference date of March 31, 2025, and aims to assess the total equity value of the target companies [2] Group 3: Evaluation Independence and Assumptions - The evaluation agency is independent, with no existing relationships or conflicts of interest with the company or the transaction parties, ensuring an unbiased assessment [2] - The assumptions set by the evaluation agency are reasonable and comply with national laws and market practices, reflecting the actual conditions of the assets [2] Group 4: Evaluation Methods and Fairness - The evaluation utilized both the income approach and asset-based approach, ultimately relying on the income approach for the final valuation of the equity [3] - The evaluation process adhered to principles of independence, objectivity, and fairness, resulting in a valuation that accurately reflects the market value of the assets as of the evaluation date [3] - The transaction pricing is based on the evaluation results, ensuring fairness and reasonableness, protecting the interests of the company and its minority shareholders [3]

Core Viewpoint - The independent directors of Meinian Onehealth Healthcare Holdings Co., Ltd. have approved a series of proposals regarding the acquisition of equity stakes in multiple companies through a share issuance, which is expected to enhance the company's business structure and profitability [1][2][3]. Group 1: Approval of Proposals - The independent directors have reviewed and approved the proposal for the company to issue shares for asset acquisition, confirming compliance with relevant laws and regulations [1]. - The transaction plan for issuing shares to purchase assets and related party transactions has been deemed reasonable and operable, benefiting the company's business structure and shareholder interests [2]. - The independent directors have also approved the draft report related to the share issuance for asset acquisition, affirming its compliance with legal requirements [2]. Group 2: Transaction Characteristics - The transaction involves acquiring stakes in 11 companies, including Hengyang Meinian Health Checkup Center Co., Ltd., and minority stakes in 5 subsidiaries, including Zhengzhou Meijian Health Management Co., Ltd. [1]. - The transaction is classified as a related party transaction due to the involvement of a company controlled by the actual controller of Meinian [3]. - It has been confirmed that the transaction does not constitute a major asset restructuring as the assets involved do not exceed 50% of the company's relevant financial metrics [4]. Group 3: Compliance and Procedures - The independent directors have confirmed that the transaction adheres to the regulatory requirements for major asset restructuring and does not involve any recent changes in control [4][5]. - The company has fulfilled all necessary legal procedures and submitted valid legal documents for the transaction [7]. - The evaluation agency selected for the transaction has been deemed independent, and the valuation methods used are considered reasonable and fair [7][9]. Group 4: Financial Aspects - The total transaction price for the equity stakes is approximately 427.78 million yuan [9]. - The company has conducted an analysis of the impact of the transaction on immediate returns and has proposed measures to mitigate any potential dilution of returns [8]. Group 5: Authorization and Future Steps - The board of directors has requested authorization from the shareholders' meeting to handle all matters related to the transaction, including adjustments to the transaction plan and execution of necessary agreements [10].

粤开证券股份有限公司 关于交易方案调整不构成重组方案重大调整的核查意见 美年大健康产业控股股份有限公司（以下简称"美年健康"、"上市公司"） 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司（以下简称"衡阳美 年"）84.00%股权、宁德美年大健康管理有限公司（以下简称"宁德美年"）81.00% 股权、烟台美年大健康体检管理有限公司（以下简称"烟台美年"）75.00%股权、 烟台美年福田健康体检管理有限公司（以下简称"烟台美年福田"）49.00%股权、 武汉美慈奥亚科技管理有限公司（以下简称"武汉奥亚"）52.81%股权、三明美 年大健康管理有限公司（以下简称"三明美年"）85.00%股权、肥城美年健康管 理有限公司（以下简称"肥城美年"）90.00%股权、德州美年大健康体检管理有 限公司（以下简称"德州美年"）84.00%股权、连江美年大健康管理有限公司（以 下简称"连江美年"）82.00%股权、沂水美年大健康体检管理有限公司（以下简 称"沂水美年"）80.50%股权、山东美铭奥亚健康咨询有限公司（以下简称"山 东奥亚"）92.35%股权及控股子公司郑州美健健康管理有限公司（以下简称"郑 州美健"）47 ...

粤开证券股份有限公司 二条和《深圳证券交易所上市公司自律监管指引第 8 号 ——重大资产重组》第三十条规定情形的核查意见 美年大健康产业控股股份有限公司（以下简称"美年健康"、"上市公司"） 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司84.00%股权、宁德美 年大健康管理有限公司81.00%股权、烟台美年大健康体检管理有限公司75.00% 股权、烟台美年福田健康体检管理有限公司49.00%股权、武汉美慈奥亚科技管理 有限公司52.81%股权、三明美年大健康管理有限公司85.00%股权、肥城美年健康 管理有限公司90.00%股权、德州美年大健康体检管理有限公司84.00%股权、连江 美年大健康管理有限公司82.00%股权、沂水美年大健康体检管理有限公司80.50% 股权、山东美铭奥亚健康咨询有限公司92.35%股权及控股子公司郑州美健健康管 理有限公司47.37%少数股权、广州花都区美年大健康管理有限公司49.00%少数 股权、安徽美欣健康管理咨询有限公司42.46%少数股权、淄博美年大健康管理有 限公司49.00%少数股权、吉林市昌邑区美年大健康科技管理有限公司48.05%少 数股权（以下简称"本次 ...

营所需的相应资质，标的资产的过户不涉及立项、环保、行业准入、用地、规划、 建设施工等有关报批事项。本次交易涉及的有关审批事项已在本报告书中详细披 露，并对本次交易无法获得批准或核准的风险作出了特别提示; 转让的情形；标的公司不存在出资不实或者影响其合法存续的情况，在相关法律 程序和先决条件得到适当履行和满足的情形下，标的资产过户至公司名下不存在 实质性法律障碍； 与关联人保持独立，符合中国证监会关于上市公司独立性的相关规定。本次交易 有利于提高公司资产的完整性，有利于公司在人员、采购、生产、销售、知识产 权等方面继续保持独立； 大不利变化；有利于上市公司突出主业、增强抗风险能力；有利于上市公司增强 独立性，不会导致新增重大不利影响的同业竞争，以及严重影响独立性或者显失 公平的关联交易。 粤开证券股份有限公司 关于本次交易符合《上市公司监管指引第 9 号——上市公 司筹划和实施重大资产重组的监管要求》第四条规定的核 查意见 美年大健康产业控股股份有限公司（以下简称"美年健康"、"上市公司"） 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司84.00%股权、宁德美 年大健康管理有限公司81.00%股权、烟台 ...

Group 1 - The asset evaluation report is prepared based on the Chinese Asset Evaluation Standards and aims to assess the value of the entire equity of Wuhan Meici Aoya Technology Management Co., Ltd. for the purpose of issuing shares to purchase assets by Meinian Health Industry Holdings Co., Ltd. [1][2] - The evaluation was conducted by Jinzheng (Shanghai) Asset Evaluation Co., Ltd. using the income method and asset-based method, with a market value assessment date of March 31, 2025 [5][7]. - The assessed market value of the entire equity of the evaluated unit is RMB 83 million (8,300.00 million) as of the evaluation base date [7][28]. Group 2 - The evaluated unit, Wuhan Meici Aoya Technology Management Co., Ltd., was established in December 2017 and focuses on health check-ups, health consulting, and management services [9][10]. - The company has a registered capital of RMB 80.8276 million and operates in Wuhan, with its business scope including medical services and health consulting [9][10]. - The financial status of the evaluated unit shows total assets of RMB 56.89 million, total liabilities of RMB 37.31 million, and total equity of RMB 19.58 million as of March 31, 2025 [28][29]. Group 3 - The evaluation report indicates that the assessed unit's main assets include current assets, fixed assets, intangible assets, and other non-current assets, with fixed assets comprising 1,510 pieces of equipment valued at RMB 29.66 million [29]. - The company has established branches and offers a range of health check-up products tailored to different age groups, addressing common health issues [17][21]. - The revenue model includes income from health check-up services, with a focus on both group and individual clients, and the company aims to provide a comprehensive health management solution [24][25].

Group 1 - The Beijing Municipal Government has released 96 local standards, including 69 new and 27 revised standards, aimed at improving various sectors [1] - The "Health Examination Quality Control Specification" is the first health examination standard collaboratively developed by Beijing, Tianjin, and Hebei, focusing on quality control in health examination services [1] - The standard emphasizes comprehensive quality control throughout the health examination process, including pre-examination, during examination, and post-examination phases, enhancing service quality and safety in the region [1] Group 2 - The "Electric Vehicle Charging Infrastructure Planning and Design Standard" mandates that 100% of new residential projects must include charging infrastructure, optimizing the planning and design of charging facilities [2] - This standard aims to improve the efficiency of parking resources and charging facilities by aligning charging characteristics with travel patterns in different public building contexts [2] - The "Food Safety Management Specification for Large Events" clarifies the responsibilities of organizing units, food suppliers, and inspection agencies, providing a scientific and standardized approach to food safety management for large events in Beijing [2] Group 3 - The "Administrative Mediation Service Specification for Consumer Disputes" is the first local standard in China addressing administrative mediation for consumer disputes, detailing service requirements and processes [3] - This standard aims to enhance the efficiency of mediation services and improve the enforcement level of market regulation, contributing to a better consumer environment in Beijing [3] - The "Technical Requirements for Indoor Emergency Shelters in Primary and Secondary Schools" outlines the conversion of schools into emergency shelters without disrupting educational functions, promoting standardized emergency management practices [3]

Core Viewpoint - The health management industry in China has shown significant growth over the past two decades, with increasing market demand driven by the public's awareness and self-management of health. The market size is projected to reach 12,555.2 billion yuan in 2024 and approximately 13,225.5 billion yuan in 2025, indicating a robust growth trajectory [1][6][21]. Industry Definition and Necessity - Health management is defined as a comprehensive monitoring and evaluation of individual or group health, providing consultation and intervention to improve health levels. It originated in the late 1950s in the United States, focusing on controlling disease occurrence and reducing medical expenses [2][3][4]. Current Development Status - The health management industry in China has achieved remarkable results, with a projected market size of 12,555.2 billion yuan in 2024, and expected growth to 13,225.5 billion yuan in 2025. The demand for health management services continues to rise as public awareness increases [6][8]. Market Structure - In 2024, the health management market structure is expected to consist of 20.58% from health check-ups, 74.48% from health insurance premiums, and 4.94% from other services. By 2025, these figures are projected to shift to 21.38%, 73.18%, and 5.44%, respectively [8]. Industry Chain - The health management industry chain includes upstream suppliers of software, medical devices, and health monitoring tools, midstream health check-up institutions, and downstream health consulting services targeting individuals, corporate employees, and government agencies [10]. Development Environment and Policies - The concept of health management was introduced in China in the late 20th century, gaining traction with government initiatives like the "Healthy China 2020" strategy. Various policies have been implemented to support the development of the health management industry, emphasizing the importance of health services in economic transformation [12][14]. Competitive Landscape - The health management industry in China is characterized by intense competition, with major players including Meinian Health, Ruici Medical, and various tech companies like Xiaomi and Huawei. The market is diverse, catering to different demographic groups and health management needs [15][17]. Key Companies - Meinian Health focuses on health check-ups and integrates health consulting and intervention services, achieving a revenue of 10.702 billion yuan and a net profit of 282 million yuan in 2024 [17]. - Ruici Medical, a leading health check-up chain, reported a revenue of 2.924 billion yuan and a net profit of 297 million yuan in 2024, emphasizing customized health check-up services [19]. Development Recommendations - The health management industry should focus on building a comprehensive system that includes public hospitals, private chains, and online platforms to enhance service delivery. There is a need for specialized talent in health management, and public awareness campaigns should be intensified to promote health management practices [21][22][25].

本报讯（记者王薇）昨天，市市场监管局发布消息，本市近日发布96项地方标准，69项为首次制定，27 项为修订标准。其中，《自动驾驶地图数据交换及服务接口规范》填补了国内自动驾驶地图数据服务共 享标准空白；新修订的《电动汽车充电基础设施规划设计标准》优化了办公、商业、学校、医院等公共 建筑的配建需求；《室内型应急避难场所平急转换技术要求中小学校》助推本市室内应急避难资源"平 急两用"，提升了城市安全韧性水平。 本市还对《电动汽车充电基础设施规划设计标准》进行了修订，标准落实"将100%建设充电基础设施或 电力线缆入固定车位纳入新建住宅配建要求"，强化了新建住宅项目充电基础设施规划设计，提供了可 供选择的居住区充电设施配建方案，确保符合安全要求的停车位具备直接装表接电条件。另外，根据交 通出行场景特征的差异化，优化了办公、商业、学校、医院等公共建筑分类配建要求，更新了直接建设 充电设施的停车位比例，使充电特征与出行特征在时间和空间两个维度上互相匹配，促进停车资源和充 电设施的高效利用。 新修订的《住宅物业服务标准》创新设置了刚性指标不分级，柔性指标分三级的方式，业主可以根据实 际情况和需求选定相应的服务标准，实现服 ...

从"朋克养生"到"硬核自律" 咱大北京的"健康自由"又该如何实现？ 过去一年 北京市"主力军"的健康状况 是逆风翻盘还是持续"摆烂"？ 北京爷们儿的"重量级"烦恼真的只是面子问题？ 女性得结节的概率，到底有多高？ 男性也会得乳腺癌，是真的吗？ 6月27日，爱康集团连续第二年联合新京报社发布《2025版北京市体检人群抽样健康报告》（以下简称《北京健康报告》），北京大学中国卫生经济研究中 心提供学术支持，旨在通过体检大数据的深度分析为北京居民解码"健康谜题"，提醒北京居民及时关注自身健康问题和疾病防控的重点。 今年是爱康集团第四次针对北京市体检人群发布健康报告，研究对象为2024年4月1日至2025年3月31日在爱康集团旗下北京体检中心参加体检的近150万人。 现场，新京报社副社长郭强，北京市健康管理协会会长高小俊，爱康集团首席康复专家、爱康悦养旗舰中心院长、美国医学科学院国际院士、亚洲与大洋洲 物理医学与康复医学 (AOPRM）主席励建安教授，国家癌症中心/中国医学科学院肿瘤医院防癌科副主任、主任医师张凯，爱康集团创始人、董事长兼CEO 张黎刚等出席发布会。 01 描绘城市人口"健康画像" 让管理有"数"更有" ...